The NEDD8 pathway as a therapeutic target in HER2-amplified colorectal cancer

被引：0
|
作者：
Invrea, F. [1 ]
Carugo, A. [2 ]
Arena, S. [3 ]
Draetta, G. [2 ]
Bardelli, A. [4 ]
Medico, E. [3 ]
机构：
[1] Candiolo Canc Inst FPO IRCCS, Lab Oncogen, Candiolo, Italy
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Torino, Candiolo Canc Inst FPO IRCCS, Candiolo, Italy
[4] Univ Torino, Oncol, Turin, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
176
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [1] The NEDD8 pathway as a therapeutic target in HER2-amplified colorectal cancer
    Invrea, Federica
    Carugo, Alessandro
    Arena, Sabrina
    Bardelli, Alberto
    Draetta, Giulio F.
    Medico, Enzo
    CANCER RESEARCH, 2022, 82 (12)
  • [2] The NEDD8 pathway as a therapeutic target in HER2-amplified colorectal cancer.
    Invrea, Federica
    Carugo, Alessandro
    Petti, Consalvo
    Draetta, Giulio
    Medico, Enzo
    CANCER RESEARCH, 2022, 82 (23)
  • [3] Identification of MAPK and mTOR pathway alterations in HER2-amplified colorectal cancer
    Cheng, Svea
    Gonzalez, Cyndi
    Ferrell, Morgan
    Giza, Richard
    Syed, Masood Pasha
    Magge, Tara
    Bao, Riyue
    Singhi, Aatur D.
    Saeed, Anwaar
    Sahin, Ibrahim Halil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 185 - 185
  • [4] The NEDD8 and EGFR pathways are independent therapeutic targets in colorectal cancer
    Invrea, Federica
    Carugo, Alessandro
    Petti, Consalvo
    Bristow, Cristopher
    Peoples, Michael
    Cancelliere, Carlotta
    Corrado, Alessia
    Bardelli, Alberto
    Isella, Claudio
    Draetta, Giulio F.
    Medico, Enzo
    CANCER RESEARCH, 2020, 80 (16)
  • [5] Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer
    Brown, Timothy J.
    Massa, Ryan C.
    JCO ONCOLOGY PRACTICE, 2022, 18 (08) : 555 - +
  • [6] Survival outcome in HER2-amplified metastatic colorectal cancer (mCRC).
    Sawada, Kentaro
    Okamoto, Wataru
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Sakamoto, Naoya
    Fujii, Satoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [7] Final results of the HERACLES trial in HER2-amplified colorectal cancer
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    Trusolino, Livio
    Martino, Cosimo
    Bencardino, Katia
    Lonardi, Sara
    Zagonel, Vittorina
    Leone, Francesco
    Martinelli, Erika
    Ciardiello, Fortunato
    Racca, Patrizia
    Amatu, Alessio
    Palmeri, Laura
    Valtorta, Emanuele
    Ghezzi, Silvia
    Vanzulli, Angelo
    Regge, Daniele
    Veronese, Silvio
    Bardelli, Alberto
    Marsoni, Silvia
    CANCER RESEARCH, 2017, 77
  • [8] Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer
    Gatel, Pierre
    Piechaczyk, Marc
    Bossis, Guillaume
    PROTEOSTASIS AND DISEASE: FROM BASIC MECHANISMS TO CLINICS, 2020, 1233 : 29 - 54
  • [9] The NEDD8 modification pathway in plants
    Mergner, Julia
    Schwechheimer, Claus
    FRONTIERS IN PLANT SCIENCE, 2014, 5
  • [10] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Taiki Hashimoto
    Daisuke Takayanagi
    Junpei Yonemaru
    Tomoaki Naka
    Kengo Nagashima
    Erika Machida
    Takashi Kohno
    Yasushi Yatabe
    Yukihide Kanemitsu
    Ryuji Hamamoto
    Atsuo Takashima
    Kouya Shiraishi
    Shigeki Sekine
    British Journal of Cancer, 2023, 129 : 1176 - 1183
12345